Jeppe Brandstrup

Jeppe Brandstrup has a Master's Degree in Finance from Aarhus University and has also completed elective courses in Mergers & Acquisitions and Business Analysis and Valuation at Harvard University. With a background in M&A and financial analysis, Jeppe has held various positions at companies such as CellaVision, Novozymes, DSB, and Ernst & Young. Currently, Jeppe serves as the Vice President of Business Development at CellaVision, a global medtech leader within digital hematology. At Novozymes, Jeppe was a Senior Manager responsible for M&A projects and building growth platforms. Prior to that, Jeppe worked at DSB as a Senior Analyst and at Ernst & Young as an Analyst in Corporate Finance.